Answers are grounded in this paper and cite their sources.
Comparative evaluation reveals 1,8 cineole inhibits growth and migration in ovarian cancer cell lines, suggesting therapeutic potential.
Ovarian cancer is a leading cause of mortality among gynecological malignancies, primarily due to delayed diagnosis and the limited effectiveness of existing therapeutic strategies. The search for safer and more effective treatment options has led to increasing interest in plant-derived phytocompounds, which exhibit diverse biological activities with comparatively fewer adverse effects. This study evaluates and compares the effects of the phytocompound 1,8- cineole on human ovarian cancer cell lines SKOV3 and PA-1. The anti-cancer activity of 1,8 cineole was evaluated using in vitro cell viability assays, supported by cell migration-based assays to assess changes in cellular behavior following treatment. The results have reported a significant level in reduction of growth and migratory potential upon 1,8 cineole exposure, indicating their ability to interfere with key processes involved in cancer progression
No takes yet. Share an insight, caveat, or question.
Joshi et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: